Vasileios-Arsenios Lioutas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 27 | 2024 | 2648 | 3.900 |
Why?
|
| Stroke | 31 | 2024 | 9747 | 2.240 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2024 | 886 | 1.540 |
Why?
|
| Brain Ischemia | 11 | 2020 | 3000 | 1.240 |
Why?
|
| Siderosis | 2 | 2020 | 100 | 1.140 |
Why?
|
| Anticoagulants | 7 | 2024 | 4862 | 1.110 |
Why?
|
| Vitamin K | 5 | 2019 | 312 | 0.850 |
Why?
|
| Neurology | 2 | 2022 | 785 | 0.850 |
Why?
|
| Headache Disorders, Primary | 1 | 2022 | 39 | 0.800 |
Why?
|
| Vasospasm, Intracranial | 2 | 2022 | 206 | 0.790 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2022 | 1167 | 0.780 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 959 | 0.700 |
Why?
|
| Hyperglycemia | 3 | 2024 | 1393 | 0.690 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2023 | 390 | 0.670 |
Why?
|
| Insulin | 7 | 2023 | 6599 | 0.670 |
Why?
|
| CADASIL | 1 | 2020 | 83 | 0.650 |
Why?
|
| Magnesium Sulfate | 1 | 2019 | 74 | 0.620 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 814 | 0.570 |
Why?
|
| Hematoma | 2 | 2018 | 766 | 0.540 |
Why?
|
| Ischemic Attack, Transient | 2 | 2021 | 870 | 0.520 |
Why?
|
| Off-Label Use | 1 | 2017 | 185 | 0.510 |
Why?
|
| Cerebrovascular Disorders | 1 | 2022 | 1470 | 0.500 |
Why?
|
| Foramen Ovale, Patent | 1 | 2018 | 211 | 0.500 |
Why?
|
| Vertebrobasilar Insufficiency | 2 | 2014 | 113 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2024 | 36532 | 0.450 |
Why?
|
| Brain Edema | 3 | 2023 | 602 | 0.450 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 647 | 0.430 |
Why?
|
| Hypoglycemic Agents | 5 | 2022 | 3110 | 0.420 |
Why?
|
| Thrombectomy | 5 | 2021 | 681 | 0.410 |
Why?
|
| Thrombolytic Therapy | 6 | 2022 | 2059 | 0.400 |
Why?
|
| Administration, Intranasal | 5 | 2022 | 482 | 0.360 |
Why?
|
| Amblyopia | 1 | 2013 | 152 | 0.350 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 2686 | 0.350 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 1303 | 0.350 |
Why?
|
| Muscle Weakness | 1 | 2012 | 413 | 0.320 |
Why?
|
| Humans | 73 | 2024 | 765968 | 0.320 |
Why?
|
| Ischemia | 1 | 2017 | 1909 | 0.310 |
Why?
|
| Aged, 80 and over | 17 | 2024 | 59489 | 0.310 |
Why?
|
| Biomedical Research | 1 | 2024 | 3458 | 0.300 |
Why?
|
| Hypertension | 3 | 2023 | 8626 | 0.300 |
Why?
|
| Aged | 32 | 2024 | 171117 | 0.290 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 1936 | 0.280 |
Why?
|
| Hospital Mortality | 2 | 2018 | 5343 | 0.280 |
Why?
|
| Tobacco Use Disorder | 1 | 2013 | 708 | 0.280 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 15880 | 0.270 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 2709 | 0.270 |
Why?
|
| Male | 37 | 2024 | 363698 | 0.250 |
Why?
|
| Cohort Studies | 10 | 2024 | 41649 | 0.250 |
Why?
|
| Fibrinolytic Agents | 6 | 2022 | 2080 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2023 | 81514 | 0.250 |
Why?
|
| Administration, Oral | 5 | 2019 | 4015 | 0.240 |
Why?
|
| Medicare | 1 | 2023 | 6823 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5891 | 0.240 |
Why?
|
| Deferoxamine | 2 | 2022 | 154 | 0.240 |
Why?
|
| Female | 39 | 2024 | 396112 | 0.230 |
Why?
|
| Edema | 3 | 2023 | 760 | 0.230 |
Why?
|
| Middle Aged | 30 | 2024 | 223009 | 0.230 |
Why?
|
| Brain | 7 | 2023 | 27171 | 0.210 |
Why?
|
| Alcoholism | 1 | 2013 | 1975 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2021 | 24282 | 0.190 |
Why?
|
| Gross Domestic Product | 1 | 2022 | 77 | 0.190 |
Why?
|
| Treatment Outcome | 14 | 2024 | 65188 | 0.190 |
Why?
|
| Fibrinolysis | 1 | 2022 | 331 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12240 | 0.170 |
Why?
|
| Organizational Culture | 1 | 2024 | 514 | 0.170 |
Why?
|
| Prospective Studies | 11 | 2023 | 54802 | 0.170 |
Why?
|
| Hyperemia | 1 | 2021 | 224 | 0.170 |
Why?
|
| Vasoconstriction | 1 | 2022 | 594 | 0.170 |
Why?
|
| Risk Factors | 9 | 2023 | 74840 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3251 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2020 | 2966 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 532 | 0.140 |
Why?
|
| Bystander Effect | 1 | 2017 | 90 | 0.140 |
Why?
|
| Headache | 2 | 2022 | 1259 | 0.130 |
Why?
|
| Pituitary Apoplexy | 1 | 2016 | 29 | 0.130 |
Why?
|
| Workload | 1 | 2022 | 851 | 0.130 |
Why?
|
| Prognosis | 7 | 2023 | 29922 | 0.130 |
Why?
|
| Dysarthria | 1 | 2016 | 57 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8730 | 0.130 |
Why?
|
| Arteries | 1 | 2021 | 1118 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1668 | 0.130 |
Why?
|
| Blood Pressure | 3 | 2023 | 8532 | 0.130 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 639 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 10383 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2022 | 762 | 0.120 |
Why?
|
| Intracranial Hypotension | 1 | 2015 | 42 | 0.120 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2018 | 279 | 0.120 |
Why?
|
| Middle Cerebral Artery | 1 | 2016 | 268 | 0.110 |
Why?
|
| Incidence | 3 | 2023 | 21480 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2016 | 276 | 0.110 |
Why?
|
| Internationality | 1 | 2019 | 1007 | 0.110 |
Why?
|
| Disease Progression | 3 | 2020 | 13632 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2014 | 184 | 0.110 |
Why?
|
| Basilar Artery | 1 | 2014 | 206 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 322 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2016 | 190 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 259 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2015 | 576 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 2410 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 14751 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22223 | 0.100 |
Why?
|
| Magnetic Field Therapy | 1 | 2012 | 27 | 0.100 |
Why?
|
| Hospitalization | 3 | 2021 | 10808 | 0.100 |
Why?
|
| Glucose | 1 | 2023 | 4335 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2023 | 2060 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2018 | 790 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2015 | 751 | 0.090 |
Why?
|
| Patient Admission | 1 | 2018 | 1365 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 3925 | 0.090 |
Why?
|
| Pandemics | 2 | 2020 | 8703 | 0.090 |
Why?
|
| Upper Extremity | 1 | 2015 | 682 | 0.090 |
Why?
|
| Consensus | 1 | 2020 | 3202 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2190 | 0.080 |
Why?
|
| Warfarin | 1 | 2018 | 1494 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 687 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26318 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 2674 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2798 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3620 | 0.080 |
Why?
|
| Cerebral Ventricles | 2 | 2024 | 549 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1022 | 0.070 |
Why?
|
| Mental Health | 1 | 2022 | 3278 | 0.070 |
Why?
|
| Pituitary Neoplasms | 1 | 2016 | 1321 | 0.070 |
Why?
|
| Double-Blind Method | 4 | 2023 | 12437 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 12976 | 0.070 |
Why?
|
| Adult | 9 | 2023 | 223044 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4533 | 0.070 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 1262 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2780 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3446 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2023 | 8067 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9338 | 0.060 |
Why?
|
| Survival Rate | 1 | 2019 | 12795 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 20659 | 0.060 |
Why?
|
| Massachusetts | 1 | 2016 | 8875 | 0.050 |
Why?
|
| Drainage | 2 | 2022 | 1179 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2024 | 6424 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12056 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3967 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4034 | 0.050 |
Why?
|
| Time Factors | 3 | 2021 | 40065 | 0.050 |
Why?
|
| Sex Factors | 1 | 2016 | 10603 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15842 | 0.050 |
Why?
|
| United States | 3 | 2023 | 72903 | 0.040 |
Why?
|
| Medical Futility | 1 | 2022 | 136 | 0.040 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 2222 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 11499 | 0.040 |
Why?
|
| Specialization | 1 | 2024 | 777 | 0.040 |
Why?
|
| Age Factors | 1 | 2016 | 18380 | 0.040 |
Why?
|
| Perception | 1 | 2024 | 1205 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 42500 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2018 | 292 | 0.040 |
Why?
|
| Acute Disease | 2 | 2020 | 7232 | 0.030 |
Why?
|
| Water | 1 | 2023 | 1417 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2018 | 268 | 0.030 |
Why?
|
| Eating | 1 | 2023 | 1540 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18293 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15652 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2020 | 970 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2015 | 310 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 1731 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 200 | 0.030 |
Why?
|
| Radial Artery | 1 | 2016 | 189 | 0.030 |
Why?
|
| Women's Health | 1 | 2023 | 2084 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 59889 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2015 | 249 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 170 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 39193 | 0.030 |
Why?
|
| Body Composition | 1 | 2023 | 2439 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1282 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 1997 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2844 | 0.030 |
Why?
|
| Child | 1 | 2020 | 80564 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 88835 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2019 | 896 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2016 | 1381 | 0.020 |
Why?
|
| Cognition | 2 | 2020 | 7049 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1751 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2023 | 9649 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 4058 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1748 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2016 | 1087 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4427 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 1938 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2631 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2904 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1792 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3449 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 3559 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8297 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3819 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 6209 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7123 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 168764 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15398 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 30260 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9347 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8923 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5189 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12807 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 16047 | 0.010 |
Why?
|
| Heart Failure | 1 | 2021 | 11840 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 18071 | 0.010 |
Why?
|